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Engulfment of apoptotic cells is an active process coordi-
nated by receptors on phagocytes and ligands on apoptotic
cells [1]. Phosphatidylserine (PtdSer) is a key ligand on
apoptotic cells, and recently three PtdSer recognition recep-
tors have been identified, namely, TIM-4, BAI1, and Stabilin-2
[1–6]. Whereas BAI1 is dependent on the ELMO1/Dock180/
Rac signaling module, and Stablilin-2 appears to use the
intracellular adaptor GULP [2, 3, 7], little is known about
how TIM-4 transduces signals downstream of PtdSer recog-
nition [8]. To test the role of known engulfment signaling
pathways inTIM-4-mediatedengulfment,weusedacombina-
tion of dominant-negative mutants, knockdown of specific
signaling proteins, and knockout cell lines. TIM-4 appears
to be largely independent of the two known engulfment
signaling pathways [7, 9–17], yet the TIM-4-mediated uptake
is inhibited by cytoskeleton disrupting drugs. Remarkably,
a version of TIM-4 lacking its cytoplasmic tail promoted
corpse uptake via PtdSer recognition. Moreover, replace-
ment of the transmembrane region of TIM-4 with a glyco-
phosphatidylinositol anchor still promoted engulfment
comparable to wild-type TIM-4. Thus, the transmembrane
region and cytoplasmic tail of TIM-4 are dispensable for
apoptotic cell engulfment, and we propose that TIM-4 is
a PtdSer tethering receptor without any direct signaling of
its own.
Results and Discussion
Both TIM-4 and BAI1 have been shown to recognize PtdSer and
enhance engulfment of apoptotic cells [3,5]. First, we confirmed
that TIM-4 and BAI1 could promote engulfment under the assay
conditions tested. Expression of either TIM-4 or BAI1 in LR73
cells strongly promoted engulfment of targets compared to
control GFP-alone-transfected cells; however, coexpression
of TIM-4 and BAI1 together did not increase engulfment
greater than TIM-4 alone (Figure 1A and Figure S1A, available
online).
To address the mode of signaling downstream of TIM-4, we
focused on the evolutionarily conserved cytoplasmic signaling
pathways linked to engulfment [18]. The first pathway involves
the ELMO1/Dock180/Rac signaling module, where the ELMO
and Dock180 proteins function together as a guanine-
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subsequent Rac-dependent cytoskeletal rearrangements
help in the formation of phagocytic arms that pull the corpses
into the phagocyte. The second pathway includes the cyto-
plasmic adaptor protein GULP, whose C. elegans homolog
CED-6 has also been shown to function upstream of Rac. To
test the functional dependency of TIM-4 on the ELMO1/
Dock180/Rac signaling module, we transiently transfected
TIM-4 with wild-type or a mutant form of ELMO [denoted
E1(T625), lacking its ability to bind Dock180], a mutant form
of Dock180 (denoted D-ISP, which fails to bind Rac and is
unable to mediate GEF activity), or a dominant-negative
mutant of Rac (denoted Rac N, with an asparagine mutation
at residue 17) and assessed the engulfment of apoptotic
thymocytes. TIM-4 did not show any cooperative effects on
engulfment when coexpressed with ELMO1 and Dock180. In
contrast, under these same conditions, BAI1, which has previ-
ously been known to function upstream of ELMO1/Dock180,
showed enhanced uptake of apoptotic thymocytes when
cotransfected with these proteins. Moreover, when LR73 cells
were cotransfected with TIM-4 and D-ISP, there was no signif-
icant inhibition compared to TIM-4 alone. Intriguingly, after
cotransfection of TIM-4 with E1(T625) mutant of ELMO1 or
RacN, we found a partial reduction in engulfment, although
the uptake due to TIM-4 under these conditions was still higher
than the GFP-alone control condition. In contrast, BAI1-medi-
ated uptake was strongly inhibited by dominant-negative
versions of ELMO1, Dock180, and Rac, to levels lower
than the control GFP-transfected condition (Figure 1A and
Figure S1A). This prompted us to further probe the depen-
dency of TIM-4 on ELMO1 and/or Rac. When we tested
whether stimulation of cells expressing TIM-4 with apoptotic
targets could activate Rac, we did not see an increase in
GTP-Rac in TIM-4-expressing cells in a time course up to
75 min. In contrast, there was modest GTP-Rac activation in
mock-transfected cells (at 50 min) and a robust GTP-Rac
formation in BAI1-expressing cells (as early as 25 min)
(Figure 1B). When we tested whether TIM-4 could promote
engulfment in J774 macrophage cells where ELMO1 expres-
sion had been knocked down via shRNA, TIM-4 still promoted
engulfment in these cells; in contrast, BAI1 failed to promote
an enhanced uptake in these same cells with knockdown of
ELMO1 expression (Figure 1C). This suggested that ELMO1
was largely dispensable for TIM-4-mediated engulfment.
Moreover, when we directly addressed whether TIM-4 could
bind ELMO1, we could not detect a physical interaction
between the two proteins (Figure 1D). Taken together, these
data suggest that the ELMO1/Dock180/Rac module has
minimal effect on TIM-4-mediated engulfment. We surmise
that the partial inhibition seen with E1(T625) mutant or the
dominant-negative RacN could have been due to other effects
of these mutants in the transfected cells, or that TIM-4 may use
another receptor (see below) that might signal through ELMO1
and Rac.
The adaptor protein CrkII is genetically placed in the same
signaling pathways as ELMO1, Dock180, and Rac proteins
and can influence ELMO1/Dock180/Rac-mediated signaling
during engulfment [17]. To test the possible involvement of
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347Figure 1. TIM-4-Mediated Engulfment Is Largely Independent of Components in the Two Known Engulfment Signaling Pathways
(A) LR73 fibroblasts were transiently transfected with the indicated plasmids. One day after transfection, the cells were incubated with red-fluorescent-
labeled apoptotic thymocytes for 2 hr, extensively washed with ice-cold PBS, trypsinized, and subjected to FACS analysis. Cells expressing equivalent
levels of protein were gated on the basis of GFP expression and evaluated for phagocytosis according to red fluorescence. Engulfment of each sample
was normalized to GFP control and shown as n-fold in engulfment; the actual percentages of uptake for each condition is shown in Figure S1A. The following
abbreviations are used: B, BAI1; T, TIM-4; D, Dock180; E1, ELMO1; E1(T625), truncation of ELMO1 at residue 625; D-ISP, mutant of Dock180 that cannot bind
or activate Rac; and RacN, a dominant-negative form of Rac (see Supplemental Experimental Procedures).
(B) LR73 cells were transiently transfected with either BAI1 or TIM-4. One day after transfection, the cells were stimulated with 2 mm carboxylate-modified
beads for indicated time and lysed. GTP-Rac was precipitated with GST-CRIB and detected by immunoblotting. Comparable levels of expression of trans-
fected BAI1 and TIM-4 are also shown. TCL denotes total cell lysates.
(C) J774 macrophages stably expressing shRNA against elmo1 (or control shRNA-expressing cells) were transfected with TIM-4 or BAI1 and assessed for
engulfment of apoptotic thymocytes.
(D) LR73 cells were transfected with ELMO1-Flag together with either TIM-4 or Dock180. ELMO1 was immunoprecipitated and assessed for coprecipitation
of TIM-4 or Dock180. TCL denotes total cell lysates.
(E and F) The ability of TIM-4 to promote engulfment was assessed in crk2/2 MEF cells or LR73 cells with a knockdown of GULP. Data are shown as
mean 6 SD and are representative of at least two independent experiments. **p < 0.01, ***p < 0.001.CrkII in TIM-4-mediated signaling, we used crk2/2 MEF cells
(Figure S1C). Although the crk2/2 mouse embryonic fibro-
blasts (MEFs) showed a substantial reduction in basal uptake
of targets compared to wild-type MEFs, transient expression
of TIM-4 still strongly promoted uptake (Figure 1E). Addition-
ally, we could not detect the interaction of TIM-4 with CrkII
(Figure S1D).
We next tested whether TIM-4 depended on GULP-medi-
ated signaling to initiate engulfment. Expression of TIM-4
together with mutants of GULP did not affect TIM-4-mediated
engulfment (Figure S1E). TIM-4 also strongly promoted uptake
in LR73 cells with stable knockdown of GULP (Figure 1F and
Figure S1F). Collectively, these data suggest that TIM-4-medi-
ated engulfment is largely independent of the cytoplasmic
signaling proteins that have been implicated in the known
pathways of apoptotic cell engulfment.
In the above engulfment experiments, despite the many
washes for unbound or loosely bound targets, it was formally
possible that TIM-4 simply enhanced the ‘‘tight’’ binding
between apoptotic targets and phagocytic cells without
necessarily leading to internalization of the targets. Using an
assay that distinguishes internalization versus binding, weconfirmed that the observed TIM-4-mediated uptake repre-
sented targets that had been completely internalized
(Figure 2A).
We next asked whether the enhanced engulfment mediated
by TIM-4 was energy dependent and/or sensitive to drugs that
disrupt the cytoskeleton. When we slowed down ATP-depen-
dent cellular processes with sodium azide (Figure S1G) or by
incubation at 4C (Figure 2A), both of these treatments
severely disrupted engulfment. These data suggest that TIM-
4-mediated engulfment relies on ATP-dependent cellular
processes.
It is well established that actin rearrangement is required to
form the phagocytic cup around an apoptotic cell, and recently
myosin-II motor proteins have also been implicated in drag-
ging apoptotic cells into the phagocyte during engulfment
[19, 20]. It is possible that TIM-4-mediated engulfment can
occur via cooperation of both the actin cytoskeleton and
myosin-II motor proteins. To determine the role of actin micro-
filaments on TIM-4 promotion of uptake, we treated LR73 cells
expressing either TIM-4 or BAI1 with cytochalasin D, an inhib-
itor of actin polymerization, and the engulfment of targets was
decreased (Figure 2B). To evaluate myosin dependence, we
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kinase of myosin-II; both TIM-4- and BAI1-mediated engulf-
ment of targets was strongly attenuated (Figure 2C). These
data suggest that cytoskeletal rearrangement, as well as the
function of myosin motor proteins, is required for TIM-4-medi-
ated engulfment.
Among the three recently identified PtdSer receptors, the
downstream signaling pathways of BAI1 and stablilin-2 have
been relatively well delineated whereas that of TIM-4 remains
elusive [3, 7, 8]. To better understand the signaling downstream
of TIM-4, we generated a cytoplasmic tailless TIM-4. Tailless
TIM-4 was comparably expressed at the cell surface as full-
length TIM-4 (right panel, Figure 3A). Surprisingly, cells tran-
siently expressing the tailless TIM-4 were quite efficient in
enhancing engulfment, comparable to full-length TIM-4
(Figure 3A). In contrast, engulfment via BAI1 was severely
reduced in cells transiently expressing the cytoplasmic tail-
deleted version of BAI1 (left panel, Figure 3A). Because it was
Figure 2. TIM-4-Mediated Engulfment Requires Intact Cytoskeleton and
Myosin-II Motor Proteins
(A) TIM-4-transfected LR73 cells were assessed for binding versus internal-
ization of labeled apoptotic thymocytes compared to control GFP-trans-
fected cells (see Supplemental Experimental Procedures).
(B and C) LR73 cells transiently expressing TIM-4, BAI1, or GFP were
pretreated with 1 mM of cytochalasin D or 30 mM of ML-7, and the uptake
of apoptotic thymocytes was assessed. Data are shown as mean 6 SD
and are representative of at least two independent experiments.possible that the enhanced engulfment by tailless TIM-4 might
have resulted simply from increased binding of targets, rather
than full internalization, we assessed the status of bound
versus internalized targets. We found no difference between
tailless and full-length TIM-4, suggesting that tailless TIM-4
can promote the efficient internalization of bound targets
(Figure 3B). We also tested whether tailless TIM-4-mediated
uptake still involved PtdSer recognition. On the basis of the
previous crystallographic studies of the TIM-4:PtdSer
complex, we mutated key amino acids within the PtdSer
binding cavity of TIM-4 IgV domain in the context of tailless
TIM-4 [6, 21]. Promotion of corpse uptake was completely
abrogated in the triple mutant TIM-4 TLAAA, which carries
a mutation to alanine of three residues in the CC’ and FG loops
of TIM-4 (WFN residues within the sequence WFND119-122); in
contrast, the single mutation (TIM-4 TLW119A) showed minimal
reduction of engulfment (left panel, Figure 3C). It is noteworthy
that this TIM-4 TLAAA mutant was expressed on the cell surface
comparable to full-length TIM-4 (right panel, Figure 3C). These
data suggest that the cytoplasmic tail of TIM-4 is dispensable
for engulfment and that engulfment by the tailless TIM-4 is still
occurs via PtdSer recognition on targets.
Because the cytoplasmic domain of TIM-4 appears nones-
sential, TIM-4 could promote engulfment through interaction
with another transmembrane receptor that mediates the
engulfment signal. Such an interaction could be mediated
either through the transmembrane region of TIM-4 or its extra-
cellular domain. To directly test whether the transmembrane
region of TIM-4 was essential, we generated a glycophospha-
tidylinositol (GPI)-anchored chimera TIM-4. For this we
replaced the cytoplasmic tail and transmembrane region of
TIM-4 with the last 37 amino acids of decay-accelerating factor
(DAF), which has been shown to target the protein to the
plasma membrane via the GPI anchor [22]. First we confirmed
cell-surface expression of the GPI anchored TIM-4, which was
comparable to full-length and tailless TIM-4 (right panel,
Figure 3D). Interestingly, the GPI-anchored chimera of TIM-4
still promoted engulfment of targets comparably to that of
full-length or tailless TIM-4 (left panel, Figure 3D). We also
confirmed that the increased engulfment mediated by the
GPI-anchored version of TIM-4 scored here resulted from
increased internalization of targets (left panel, Figure 3E).
To confirm that it was the membrane-bound GPI-anchored
TIM-4 that was mediating the uptake, we incubated the cells
expressing GPI-TIM-4 with a PI-specific phospholipase C
(PI-PLC), which cleaves the GPI-anchored proteins from the
cell surface. Treatment with PI-PLC resulted in greater then
80% reduction in the amount of GPI-TIM-4 on the cell surface,
as determined by flow cytometry (Figure 3F). In contrast,
surface expression of full-length and tailless TIM-4 was unaf-
fected by treatment with PI-PLC (Figure 3F). When tested
for engulfment, LR73 cells expressing GPI-TIM-4 showed
a substantial reduction in engulfment of targets after treatment
with PI-PLC, whereas engulfment in LR73 cells expressing full-
length and tailless TIM-4 did not show any impairment
(Figure 3G). These data suggest that the transmembrane
region of TIM-4 is also dispensable for TIM-4-mediated engulf-
ment, implying that the extracellular region of TIM-4 might
interact with another transmembrane protein(s) to transmit
its signals into the cytoplasm.
The exposure of PtdSer on the apoptotic cells and its recog-
nition by phagocyte receptor(s) has been of pivotal interest in
the engulfment field, yet, until recently, the receptor(s) that
recognizes PtdSer has remained elusive. The identification
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349Figure 3. The Cytoplasmic Tail and the Transmembrane Region of TIM-4 Are Dispensable for TIM-4-Mediated Engulfment
(A) Full-length (FL) or tailless (TL) versions of TIM-4 or BAI1 (tagged on the extracellular portion with HA) were transiently expressed in LR73 cells, and after
gating on cells expressing the transfected proteins, the engulfment of apoptotic thymocytes was assessed. The cell-surface expression of full-length or
tailless of TIM-4 was assessed in parallel by flow cytometry (right panel).
(B) The fraction of apoptotic thymocytes that are bound versus internalized by LR73 cells expressing TIM-4-FL or TIM-4-TL was assessed (see Supple-
mental Experimental Procedures).
(C) The effect of mutations within the PtdSer-binding pocket of TIM-4 was assessed with the triple mutant TLAAA or the single mutant TLW119A. The cell-
surface expression of full-length or mutant proteins was confirmed (right panel).
(D) LR73 cells transfected with TIM-4, whose transmembrane and cytoplasmic regions were replaced with a GPI anchor, was assessed for its ability to
promote engulfment of apoptotic thymocytes. GPI denotes glycophosphatidylinositol linked.
(E) LR73 cells transfected with the FL, TL, or GPI version of TIM-4 (and gated on cells expressing these proteins) were assessed for binding versus inter-
nalization of apoptotic thymocyte targets in the engulfment assay.
(F and G) LR73 cells expressing FL, TL, or the GPI versions of TIM-4 were treated with PI-PLC (which cleaves GPI-anchored proteins), and the surface
expression (F) and the ability to engulf apoptotic thymocytes (G) were assessed. The surface expression of TIM-4 non-PI-PLC-treated cells was set as
100% and compared to the PI-PLC treated conditions (F). PI-PLC denotes phosphatidylinositol-specific phospholipase C. Data are shown as
mean 6 SD and are representative at least two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.005.of TIM-4, BAI1, and Stabilin-2 as three possible receptors for
PtdSer last year was received with great excitement. TIM-4
perhaps received the greatest attention of the three, as a result
of its relevance to allergic diseases, its highest expression in
macrophages, and the solved of the structure of the PtdSer
recognition domain of TIM-4 [5, 6, 21, 23, 24]. It was generally
assumed that the cytoplasmic tail of TIM-4, subsequent to
recognition of PtdSer on apoptotic cells, would induce intra-
cellular signaling to mediate engulfment; however, essentially
nothing has been known about the specific signaling pathwayused by this receptor during engulfment. Here, we have
addressed the possible modes of signaling downstream of
TIM-4 and make several important observations. First, we
demonstrate through a series of studies that TIM-4 does not
directly engage components of either of the two known
engulfment signaling pathways. Second, we show that TIM-
4-mediated engulfment requires ATP-dependent cellular
processes. Third, we also show that the cytoplasmic tail of
TIM-4 is also dispensable for engulfment. Finally, we demon-
strate that the transmembrane region of TIM-4 is dispensable
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another membrane protein(s) (perhaps associating via the
extracellular portions of TIM-4) that coordinates the signaling
after recognition of targets via TIM-4. Taken together, these
data suggest that TIM-4 is primarily a binding receptor for
PtdSer recognition and not a signaling receptor. These data
also suggest that TIM-4 should be reclassified as a tethering
receptor for PtdSer, in the same category as engulfment
receptors that purely serve an adhesion function, such as
CD14 and CD36. More intriguingly, our work also implies
that TIM-4-mediated engulfment probably relies on other
cell-surface receptors for signaling.
Experimental Procedures
Cell Culture and Reagents
293T cells and primary MEF cells were maintained in Dulbecco’s modified
Eagle’s medium containing 10% fetabl bovine serum (FBS) and the supple-
ments of penicillin-streptomycin-glutamine. The J774 macrophage cell line
was cultured in RPMI 1640 medium, and LR73 cells were maintained in
Alpha’s modified Eagle’s medium, both supplemented with 10% FBS and
penicillin-streptomycin-glutamine. 293T cells were transiently transfected
by the calcium phosphate method. LR73 and primary MEF cells were tran-
siently transfected with Lipofectamine 2000 (Invtirogen) according to the
manufacturer’s instructions. J774 cells (kit V, program T-20) were trans-
fected with the Amaxa nucleofection method according to the manufac-
turer’s recommendations. ELMO1 and GULP knockdown cell lines were es-
tablished by use of shRNA against elmo1 or gulp [3, 25].
Plasmids
All mutant constructs generated were sequenced to confirm the fidelity and
presence of the appropriate mutations. ELMO1, Dock180, and Rac1
constructs used in this study have been described previously [3]. pDis-
HA-TIM-4 was a generous gift from Vijay K. Kuchroo (Harvard Medical
School) [26]. We generated the various TIM-4 constructs from pDis-HA-
TIM-4 by a PCR-based strategy. Tailless (TL) TIM-4 construct was gener-
ated by the deletion of amino acids 306–343 of TIM-4. W199 of TIM-4 was
changed to alanine in the tailless version to generate TLW119A. Tryptophan,
phenylalanine, and asparagine (residues 119–201) were mutated into
alanines to generate TLAAA. For the generation of the gylocphosphatidylino-
sitol-anchored chimera TIM-4 (GPI-TIM-4), the transmembrane domain and
cytoplasmic tail of TIM-4 (amino acids 280–343) were deleted and the extra-
cellular region of TIM-4 was fused to the last 37 amino acid of DAF (residues
311–347).
Immunoprecipitation and Immunoblotting
293T or LR73 cells were transiently transfected, and 2 days (293T) or 1 day
(LR73) after transfection, the cells were lysed and immunoprecipitated with
antibody conjugated to agarose or glutathione sepharose. Bound proteins
were assessed by immunoblotting for the respective tags or endogenous
proteins. Flag antibody (M-3) was purchased from Sigma-Aldrich. CrkII
(C-18), GFP (B-2), and HA (F-7) antibody were purchased from Santa Cruz
Biotechnology. The anti-ELMO1 antibody has been described previously [3].
Cleavage of GPI Anchor
Treatment of cells with PI-PLC was performed according to the manufac-
turer’s recommendations. One day after transfection, LR73 cells (in 24-
well plates) were treated with 0.2 unit of PI-PLC (Molecular Probes) in
100 ml ice-cold PBS and incubated at 4C for 30 min. The apoptotic thymo-
cytes were then added to the PI-PLC-treated cells and incubated at 37C for
2 hr. For cell-surface staining of TIM-4 remaining after PI-PLC treatment,
cells were washed two times with ice-cold PBS after PI-PLC treatment,
and then stained with FITC-conjugated anti-HA antibody (Santa Cruz
Biotechnology).
Statistical Analysis
All data are shown as the mean 6 standard deviation (SD). For analysis of
statistical difference between two groups, a two-tailed t test was applied.
For analysis of statistical difference between three or more groups, a one-
way ANOVA was applied. Statistical significance was calculated with
GraphPad Prism 4 software. Significance was assumed when p values
were < 0.05.Supplemental Data
Supplemental Data include one figure and Supplemental Experimental
Procedures and can be found with this article online at http://
www.current-biology.com/supplemental/S0960-9822(09)00614-9.
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